Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Lifevantage Corporation

Company price
4.72 USD 0.16 ( 3.51%)
Last update at 2026-11-11T21:00:00Z
VOLUME
56534
Market Cap
77.42M
P/E
15.85

Momentum Score

…

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
4.63
Low
5.06
High
52 Week Price Range
3.81
Low
11.62
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

LifeVantage Corporation is a U.S. direct-selling company that sells nutritional supplements and personal-care products through a global network of distributors. Growth drivers include product innovation, international expansion and rising consumer interest in preventive health, which may support recurring sales. Investors may view the company as having an established sales infrastructure and potential for repeat revenue.
Main risks are reliance on a network-marketing model exposed to regulatory and reputational scrutiny, strong competition, and execution risk in distributor recruitment and international growth.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
4.56
Dividend Yield
2.96%
Revenue TTM
182.59M
Revenue Per Share
14.57
Gross Profit TTM
141.61M
Debt / Equity
0.29
ROE
14.87%
Net Debt
-5.05M
ROCE
14.48%
Diluted EPS TTM
0.39

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 6.07M 12.24M 4.35M 4.00M 4.69M
Net income 5.07M 9.80M 2.94M 2.54M 3.12M
Selling general administrative 58.42M 69.21M 68.47M 71.06M 63.42M
Selling and marketing expenses 77.09M - 85.92M 94.69M 97.26M
Gross profit 141.61M 183.67M 158.72M 170.01M 168.26M
Reconciled depreciation 2.77M 3.16M 3.58M 3.58M 5.05M
Ebit 6.07M 12.24M 4.35M 0.68M 1.86M
Ebitda 8.84M 15.40M 7.93M 4.26M 6.91M
Depreciation and amortization 2.77M 3.16M 3.58M 3.58M 5.05M
Non operating income net other - - - -0.46M -
Operating income 6.10M 12.20M 4.33M 4.26M 1.86M
Other operating expenses 176.49M 216.33M 195.83M 209.14M 198.78M
Interest expense - - - 0.20M 0.01M
Tax provision 0.99M 2.44M 1.41M 1.46M 1.57M
Interest income 0.16M 0.43M 0.43M 0.20M -
Net interest income 0.16M 0.43M 0.43M 0.20M -0.01M
Income tax expense 0.99M 2.44M 1.41M 1.46M 1.57M
Total revenue 182.59M 228.53M 200.16M 213.40M 206.36M
Total operating expenses 135.51M 171.47M 154.39M 165.75M 160.69M
Cost of revenue 40.97M 44.86M 41.44M 43.39M 38.10M
Total other income expense net -0.03M 0.04M 0.02M -0.46M 2.83M
Net income from continuing ops 5.07M 9.80M 2.94M 2.54M 3.12M
Net income applicable to common shares - - - 2.54M 3.12M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 62.11M 71.96M 60.30M 66.12M 70.71M
Intangible assets 3.06M 0.24M 0.32M 0.46M 0.59M
Other current assets 4.22M 6.09M 2.44M 4.75M 6.96M
Total liab 28.52M 37.32M 34.31M 31.47M 39.19M
Total stockholder equity 33.59M 34.64M 25.99M 34.65M 31.52M
Other current liab 13.14M 17.39M 10.89M 13.75M 15.59M
Common stock 0.00M 0.00M 0.00M 0.00M 0.00M
Capital stock 0.00M 0.00M 0.00M 0.00M 0.00M
Retained earnings -103.46M -104.15M -108.74M -98.31M -98.44M
Other liab - - - 0.30M 0.31M
Good will 0.47M 0.00M - - -
Other assets - - - 3.56M 2.62M
Cash 14.92M 20.20M 16.89M 21.61M 20.19M
Total current liabilities 20.23M 27.22M 22.31M 19.61M 25.73M
Current deferred revenue - 0.71M 0.86M 0.83M 0.08M
Net debt -5.05M -8.52M -3.27M -8.52M -4.43M
Short term debt 1.94M 1.87M 1.81M 1.52M 2.60M
Short long term debt total 9.87M 11.68M 13.61M 13.09M 15.76M
Other stockholder equity 138.92M 139.96M 136.64M 134.31M 131.07M
Property plant equipment - - - 9.09M 20.54M
Total current assets 38.30M 50.89M 37.65M 44.28M 46.96M
Long term investments - - - - 0.00M
Net tangible assets - - - 34.19M 30.93M
Net receivables 2.99M 3.93M 3.26M 1.85M 5.09M
Inventory 16.17M 20.67M 15.05M 16.07M 16.47M
Accounts payable 5.16M 5.06M 6.29M 3.50M 7.46M
Accumulated other comprehensive income -1.87M -1.18M -1.92M -1.36M -1.12M
Common stock total equity - - - 0.00M -
Retained earnings total equity - - - -98.31M -
Non currrent assets other 0.64M 0.60M 0.68M 0.57M 1.33M
Non current assets total 23.81M 21.06M 22.65M 21.84M 23.75M
Capital lease obligations 9.87M 11.68M 13.61M 13.09M 15.76M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -1.37M -2.25M -3.06M -1.53M
Change to liabilities - - - -4.95M 0.82M
Total cashflows from investing activities -7.31M -1.37M -2.25M -3.06M -1.53M
Net borrowings 0.00M 0.00M - - -
Total cash from financing activities -7.78M -7.60M -14.42M -2.36M -8.95M
Change to operating activities - - - -1.25M -2.03M
Net income 5.07M 9.80M 2.94M 2.54M 3.12M
Change in cash -5.28M 3.31M -4.72M 1.42M -2.98M
Begin period cash flow 20.20M 16.89M 21.61M 20.19M 23.17M
End period cash flow 14.92M 20.20M 16.89M 21.61M 20.19M
Total cash from operating activities 10.24M 11.88M 12.20M 6.83M 7.96M
Depreciation 2.77M 3.16M 3.58M 3.58M 5.05M
Other cashflows from investing activities -3.74M 0.00M 0.00M 0.01M -
Dividends paid 2.34M 2.07M 6.94M -1.59M -0.38M
Change to inventory 2.02M -5.22M 0.66M 0.06M -1.19M
Change to account receivables -0.55M -0.56M -1.50M 1.56M -0.61M
Sale purchase of stock -2.04M -3.15M -7.65M -1.02M -9.08M
Other cashflows from financing activities -3.63M -2.66M -0.10M 0.20M 0.13M
Change to netincome - - - 1.52M 3.89M
Capital expenditures 3.57M 1.37M 2.25M 3.07M 1.53M
Change receivables - - - 1.56M -
Cash flows other operating - - - 2.52M -
Cash and cash equivalents changes - - - 1.41M -
Change in working capital -4.11M -6.55M 2.38M -2.56M -4.10M
Stock based compensation 2.35M 5.70M 3.28M 3.19M 1.77M
Other non cash items 3.76M 1.47M 1.30M 1.78M 2.21M
Free cash flow 6.67M 10.51M 9.95M 3.76M 6.43M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
LFVN
Lifevantage Corporation
0.16
3.51%
4.72 15.85 37.45 0.42 2.34 0.40 8.28
NSRGF
Nestle SA
-
-%
105.38 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR
-1.57
1.50%
103.44 26.82 18.66 3.18 7.07 3.81 21.70
DANOY
Danone PK
-0.17
1.11%
15.17 24.23 17.64 1.88 2.57 1.88 11.70
GPDNF
Danone S.A
-
-%
75.55 20.30 14.75 1.65 2.24 1.76 10.92

Profile*

Lifevantage Corporation

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

3300 North Triumph Boulevard, Lehi, UT, United States, 84043

801 432 9000

209

Name Title Year Born
Mr. Steven R. Fife Pres, CEO & Director 1961
Mr. Carl A. Aure Chief Financial Officer 1973
Mr. Matthew Cooley Chief Operating Officer 1973
Ms. Alissa Neufeld Gen. Counsel & Corp. Sec. 1979
Ms. Julie Boyster Chief Marketing Officer 1985
Mr. Eric E. Marchant VP of Compliance NA
Chris Taylor Director of Communications NA
Ms. Michelle Oborn-Virchow Sr. VP of HR 1980
Ms. Calli Mott Sr. VP of Distributor Experience NA
Mr. Dave Fleming Sr. VP of Sales NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…